Clinical Trial Update: Selenium to Improve Neurological Outcome After Cardiac Arrest [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating selenium to improve neurological outcomes after cardiac arrest has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: Medical University of Graz | Conditions: Cardiac Arrest | Phase 2 | Status: WITHDRAWN